Jong Su Jeon

Title: Innovations of Jong Su Jeon

Introduction

Jong Su Jeon is a notable inventor based in Gyeongsangbuk-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of fibrosis and diabetes. With a total of 2 patents, his work showcases innovative approaches to addressing critical health issues.

Latest Patents

Jong Su Jeon's latest patents include a method of treating fibrosis, which discloses a new use of cyclo(His-Pro). This method involves administering an effective amount of an isolated cyclo(His-Pro) to a subject in need of treatment for fibrosis and/or inflammation. Additionally, he has developed a pharmaceutical composition for preventing or treating diabetes. This composition contains a zinc salt, cyclo-His-Pro, and an antidiabetic drug as active ingredients, providing a comprehensive approach to diabetes management.

Career Highlights

Jong Su Jeon is currently associated with Novmetapharma Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to developing effective treatments that can improve patient outcomes.

Collaborations

Some of his notable coworkers include Hoe Yune Jung and Do Hyun Lee, who contribute to the collaborative efforts in research and development at Novmetapharma Co., Ltd.

Conclusion

Jong Su Jeon's contributions to the field of pharmaceuticals through his innovative patents highlight his dedication to improving health outcomes. His work in treating fibrosis and diabetes demonstrates the potential of targeted pharmaceutical compositions in modern medicine.